Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction
- 1 September 1999
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 106 (3) , 634-643
- https://doi.org/10.1046/j.1365-2141.1999.01605.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantationBone Marrow Transplantation, 1997
- Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantationBone Marrow Transplantation, 1997
- Good correlation between RT-PCR analysis and relapse in Philadelphia (Ph1)-positive acute lymphoblastic leukemia (ALL)Leukemia, 1997
- The use of monoclonal gene rearrangement for detection of minimal residual disease in acute lymphoblastic leukemia of childhoodLeukemia, 1997
- In patients with BCR-ABL-positive ALL in CR peripheral blood contains less residual disease than bone marrow: Implications for autologous BMTAnnals of Hematology, 1994
- Granulocyte colony-stimulating factor (G-CSF) as an adjunct to induction chemotherapy of adult acute lymphoblastic leukemia (ALL)Annals of Hematology, 1993
- Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reactionThe Lancet, 1991
- Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene ProductsScience, 1990
- The Molecular Genetics of Philadelphia Chromosome–Positive LeukemiasNew England Journal of Medicine, 1988
- FALSE-POSITIVE RESULTS AND THE POLYMERASE CHAIN REACTIONThe Lancet, 1988